- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Saphnelo, as a targeted biological agent for the treatment of moderate to severe systemic lupus erythematosus, requires special attention to in...
Saphnelo is an innovative biological agent targeting type I interferon receptors, specifically designed for the treatment of moderate to severe...
Saphnelo is a biological agent used for the treatment of systemic lupus erythematosus (SLE), administered via intravenous infusion. The standar...
Tenapanor, as a selective NHE3 inhibitor, is mainly used for the treatment of hyperphosphatemia in dialysis patients with chronic kidney diseas...
Tenapano tablets, as a novel sodium/hydrogen exchanger 3 (NHE3) inhibitor, effectively control hyperphosphatemia in dialysis patients by inhibi...
Xphozah is a phosphorus lowering drug used for the treatment of hyperphosphatemia in dialysis patients. It is necessary to strictly follow the ...
Ditripentat HeylAmp. is a heavy metal chelating agent that specifically binds to heavy metal ions to form stable complexes that are excreted fr...
Ditripentat HeylAmp. is a chelating agent used to treat heavy metal poisoning, especially effective for poisoning caused by lead, cadmium, and ...
Patients with celecoxib need to establish a healthy lifestyle to reduce the risk of adverse drug reactions, with a focus on cardiovascular prot...
Celecoxib, as a selective COX-2 inhibitor, requires special attention to cardiovascular, gastrointestinal, and allergic risks when used. The fo...
